Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanotechnology

This article was originally published in RAJ Devices

Executive Summary

European Parliament prepares position

You may also be interested in...



Health And Wellness Trademark Review 7 July, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Device Week, 9 July 2020 –Transcatheter MV Repair CMS Coverage Update; Chats With Boston Scientific, Protaryx

In this week’s podcast, Medtech Insight's managing editor Marion Webb chats with editor-in-chief Phil Greenfield about start-up Protaryx Medical, which raised $8.3m to develop a universal catheter system for delivering beating heart treatments. Deputy editor Reed Miller discusses proposed updates by the Centers for Medicare and Medicaid Services for coverage of transcatheter mitral valve repair and reporter Catherine Longworth talks about her Exec Chat on digital transformation in health care with Boston Scientific's Angelo De Rosa. 

Sabinsa’s Curcumin Complex Reduces Inflammation In Traumatic Brain Injury Patients

Iranian researchers found using 500 mg curcumin complex daily for seven days reduced levels of leptin, which can promote inflammatory response, in patients with traumatic brain injury. In study published in Phytotherapy Research, 28 subjects had an overall 47.1% reduction in leptin.

UsernamePublicRestriction

Register

LL1132999

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel